Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Left Atrial Appendage Closure: Implantation Depth Could Determine Thrombosis Risk

Left atrial appendage closure (LAAC) has undergone significant advances over the past two decades. This progress has been driven by the development of new devices, improved procedural safety, and the growing body of evidence supporting broader clinical adoption. Despite these advances, device-related thrombosis (DRT) remains a major concern because of its association with an increased risk of thromboembolic events. Several risk factors for DRT have been identified, although most are non-modifiable. 

Among the few modifiable factors, deep device implantation has consistently emerged as one of the most significant predictors of DRT across multiple studies. Distal device implants leave a relevant portion of the left atrium exposed to blood stasis around the device surface, potentially promoting thrombus formation.

Recent advances in computational fluid dynamics (CFD) modeling have enabled patient-specific blood flow simulations to assess the risk of device-related thrombosis after LAAC. These simulations have provided valuable insights into the relationship between left atrial appendage anatomy, hemodynamics, and thrombus development. However, previous studies have been limited by small sample sizes, restricting the generalizability of their findings.

The aim of this study was to evaluate the impact of device implantation depth on blood flow dynamics after LAAC using CFD-based simulations and to explore its potential role in DRT risk stratification.

Read also: Influence of cusp-overlap and three-cusp coplanar techniques on new-onset conduction disturbances after TAVI.

The Primary Endpoint (PEP) was to compare CFD-derived flow indices — device surface velocity index (DSVI), endothelial cell activation potential (ECAP), and the presence of vortices/stagnant flow — between proximal and distal implantation groups. The Secondary Endpoint (SEP) was to explore the relationship between these flow characteristics and the rate of DRT.

The study included 285 patients who underwent LAAC with Amplatzer Amulet or WATCHMAN devices across 10 centers. Patient-specific CFD simulations were performed using postprocedural computed tomography and echocardiography to assess blood flow dynamics. The mean age was 75 years, and most patients were male.

Read also: Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak.

Proximal implants (57.2%) demonstrated more favorable flow patterns, including higher DSVI (0.11 m/s vs. 0.09 m/s; p = 0.002), lower ECAP (0.75 vs. 0.90; p = 0.003), and fewer recirculation zones (40.5% vs. 74.6%; p < 0.001). The incidence of DRT increased with greater implantation depth, in parallel with worsening flow indices. A CFD-based DRT risk score incorporating ECAP, implantation depth, and flow complexity showed good discriminatory capacity (ROC area under the curve [AUC] 0.81), outperforming anatomical depth alone (AUC 0.71).

Conclusion: Greater implantation depth after LAAC is associated with abnormal blood flow dynamics and a worse hemodynamic profile

The use of CFD simulations in patients undergoing LAAC demonstrated a clear relationship between deeper distal implantation and abnormal flow patterns associated with a higher risk of device-related thrombosis (DRT). These findings highlight the close relationship between altered blood flow dynamics and thrombus formation.

Título Original: Impact of device implantation depth on blood flow dynamics after left atrial appendage closure.

Referencia: Pedro Cepas-Guillén et al EuroIntervention 2026;22:e444-e454.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....